CF and non-CF bronchiectasis

Validation of the Bronchiectasis Impact Measure (BIM): a novel patient-reported outcome measure
Megan L. Crichton, Emily K. Dudgeon, Amelia Shoemark, James D. Chalmers

European Respiratory Journal May 2021, 57 (5) 2003156; DOI: 10.1183/13993003.03156-2020
Transcriptomic analysis of CFTR-impaired endothelial cells reveals a pro-inflammatory phenotype
Mathias Declercq, Pauline de Zeeuw, Nadine V. Conchinha, Vincent Geldhof, Anabela S. Ramalho, Melissa García-Caballero, Katleen Brepoels, Marjolein Ensinck, Marianne S. Carlon, Matthew J. Bird, Stefan Vinckier, Marijke Proesmans, François Vermeulen, Lieven Dupont, Bart Ghesquière, Mieke Dewerchin, Peter Carmeliet, David Cassiman, Lucas Treps, Guy Eelen, Peter Witters

European Respiratory Journal Apr 2021, 57 (4) 2000261; DOI: 10.1183/13993003.00261-2020
Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients
Jennifer A. Bartell, Lea M. Sommer, Rasmus L. Marvig, Marianne Skov, Tacjana Pressler, Søren Molin, Helle Krogh Johansen

European Respiratory Journal Apr 2021, 57 (4) 2000512; DOI: 10.1183/13993003.00512-2020
Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis
Anabela S. Ramalho, Eva Fürstová, Annelotte M. Vonk, Marc Ferrante, Catherine Verfaillie, Lieven Dupont, Mieke Boon, Marijke Proesmans, Jeffrey M. Beekman, Ifat Sarouk, Carlos Vazquez Cordero, Francois Vermeulen, Kris De Boeck

European Respiratory Journal Jan 2021, 57 (1) 1902426; DOI: 10.1183/13993003.02426-2019
Efficacy and safety of TOBI Podhaler in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study
Michael R. Loebinger, Eva Polverino, James D. Chalmers, Harm A.W.M. Tiddens, Herman Goossens, Michael Tunney, Felix C. Ringshausen, Adam T. Hill, Rashidkhan Pathan, Gerhild Angyalosi, Francesco Blasi, Stuart J. Elborn, Charles S. Haworth

European Respiratory Journal Jan 2021, 57 (1) 2001451; DOI: 10.1183/13993003.01451-2020
The assessment of short- and long-term changes in lung function in cystic fibrosis using ¹²⁹Xe MRI
Laurie J. Smith, Alex Horsley, Jody Bray, Paul J.C. Hughes, Alberto Biancardi, Graham Norquay, Martin Wildman, Noreen West, Helen Marshall, Jim M. Wild

European Respiratory Journal Dec 2020, 56 (6) 2000441; DOI: 10.1183/13993003.00441-2020
Sputum neutrophil elastase associates with microbiota and Pseudomonas aeruginosa in bronchiectasis
Martina Oriano, Andrea Gramegna, Leonardo Terranova, Giovanni Sotgiu, Imran Sulaiman, Luca Ruggiero, Laura Saderi, Benjamin Wu, James D. Chalmers, Leopoldo N. Segal, Paola Marchisio, Francesco Blasi, Stefano Aliberti

European Respiratory Journal Oct 2020, 56 (4) 2000769; DOI: 10.1183/13993003.00769-2020
Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies
James D. Chalmers, David Cipolla, Bruce Thompson, Angela M. Davis, Anne O'Donnell, Gregory Tino, Igor Gonda, Charles Haworth, Juergen Froehlich

European Respiratory Journal Oct 2020, 56 (4) 2000110; DOI: 10.1183/13993003.00110-2020
Morbidity and mortality in carriers of the cystic fibrosis mutation CFTR Phe508del in the general population
Yunus Çolak, Børge G. Nordestgaard, Shoaib Afzal

European Respiratory Journal Sep 2020, 56 (3) 2000558; DOI: 10.1183/13993003.00558-2020
Inhaled aztreonam improves symptoms of cough and sputum production in patients with bronchiectasis: a post hoc analysis of the AIR-BX studies
Megan L. Crichton, Mike Lonergan, Alan F. Barker, Oriol Sibila, Pieter Goeminne, Amelia Shoemark, James D. Chalmers

European Respiratory Journal Jul 2020, 56 (1) 2000608; DOI: 10.1183/13993003.00608-2020

Main menu

User menu

Search

CF and non-CF bronchiectasis

Pages

Contact us